GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Empower Clinics Inc (OTCPK:EPWCF) » Definitions » Peter Lynch Fair Value

Empower Clinics (Empower Clinics) Peter Lynch Fair Value : N/A (As of Apr. 30, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Empower Clinics Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Empower Clinics's Peter Lynch Fair Value or its related term are showing as below:



EPWCF's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.325
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Empower Clinics Peter Lynch Fair Value Historical Data

The historical data trend for Empower Clinics's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Empower Clinics Peter Lynch Fair Value Chart

Empower Clinics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Empower Clinics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Empower Clinics's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, Empower Clinics's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Empower Clinics's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Empower Clinics's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Empower Clinics's Price-to-Peter-Lynch-Fair-Value falls into.



Empower Clinics Peter Lynch Fair Value Calculation

Empower Clinics's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *-0.108
=N/A

Empower Clinics's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.11.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Empower Clinics  (OTCPK:EPWCF) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Empower Clinics's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.0001/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Empower Clinics Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Empower Clinics's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Empower Clinics (Empower Clinics) Business Description

Traded in Other Exchanges
N/A
Address
1771 Robson Street, Suite 505, Vancouver, BC, CAN, V6G 1C9
Empower Clinics Inc is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and medical diagnostics laboratories. The company has a clinical and digital presence across North America. The firm's Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of its patients, while simultaneously providing long-term value for its shareholders.
Executives
John Kenneth Campbell director 905 WEST PENDER ST STE 500, VANCOUVER BC CANADA A1 V6C1L6
Dan Brown director 4615 232ND STREET, LANGLEY A1 V2Z 2S1
Michael Barry Hart officer: Pres/Prin Exe Officer/Sec/Trea 3331 BEACH AVE, ROBERTS CREEK A1 V0N 2W2
Garth Johnson officer: CFO 1407 - 1050 BURRARD ST., VANCOUVER A1 V6Z 2S3
Trans Orient Petroleum Ltd/ 10 percent owner WORLD TRADE CENTRE, SUITE 404-999 CANADA PLACE, VANCOUVER A1 V6C 3E2
Robert Pollock 10 percent owner 94 GARFIELD AVENUE, TORONTO A6 M4T 1G1
Doug Lynes director SUITE 350 - 6165 HIGHWAY 17, DELTA A1 V4K 5B8
Alex Guidi 10 percent owner 1055 WEST GEORGIA STREET, SUITE 1500, VANCOUVER A1 V6E 4N7